Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 191 entries
Sorted by: Best Match Show Resources per page
SEL-focused after-school programs

after-school interventions

Hurd N, Deutsch N.
GSID: R3Syno4KjnIJ
N Hurd, N Deutsch - The Future of Children, 2017 - JSTOR

… to SEL interventions that occur outside of school hours. But rather than consider all out-of-school contexts, we limit our scope to after-school … In any case, most of the research on SEL interventions in out-ofschool contexts has taken...

Cite
Hurd, N., & Deutsch, N. (2017). SEL-focused after-school programs. The Future of Children, 95-115.
Hurd, Noelle, and Nancy Deutsch. "SEL-focused after-school programs." The Future of Children (2017): 95-115.
Copy Download .nbib Format: MLA
Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties.

Frontiers in pharmacology

Batke M, Gütlein M, Partosch F, Gundert-Remy U, Helma C, Kramer S, Maunz A, Seeland M, Bitsch A.
PMID: 27708580
Front Pharmacol. 2016 Sep 21;7:321. doi: 10.3389/fphar.2016.00321. eCollection 2016.

Interest is increasing in the development of non-animal methods for toxicological evaluations. These methods are however, particularly challenging for complex toxicological endpoints such as repeated dose toxicity. European Legislation, e.g., the European Union's Cosmetic Directive and REACH, demands the...

Cite
Batke M, Gütlein M, Partosch F, et al. Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties. Front Pharmacol. 2016;7:321doi: 10.3389/fphar.2016.00321.
Batke, M., Gütlein, M., Partosch, F., Gundert-Remy, U., Helma, C., Kramer, S., Maunz, A., Seeland, M., & Bitsch, A. (2016). Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties. Frontiers in pharmacology, 7321. https://doi.org/10.3389/fphar.2016.00321
Batke, Monika, et al. "Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties." Frontiers in pharmacology vol. 7 (2016): 321. doi: https://doi.org/10.3389/fphar.2016.00321
Batke M, Gütlein M, Partosch F, Gundert-Remy U, Helma C, Kramer S, Maunz A, Seeland M, Bitsch A. Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties. Front Pharmacol. 2016 Sep 21;7:321. doi: 10.3389/fphar.2016.00321. eCollection 2016. PMID: 27708580; PMCID: PMC5030828.
Copy Download .nbib Format: NLM
Engineering of Metabolic Pathways by Artificial Enzyme Channels.

Frontiers in bioengineering and biotechnology

Pröschel M, Detsch R, Boccaccini AR, Sonnewald U.
PMID: 26557643
Front Bioeng Biotechnol. 2015 Oct 21;3:168. doi: 10.3389/fbioe.2015.00168. eCollection 2015.

Application of industrial enzymes for production of valuable chemical compounds has greatly benefited from recent developments in Systems and Synthetic Biology. Both, in vivo and in vitro systems have been established, allowing conversion of simple into complex compounds. Metabolic...

Cite
Pröschel M, Detsch R, Boccaccini AR, et al. Engineering of Metabolic Pathways by Artificial Enzyme Channels. Front Bioeng Biotechnol. 2015;3:168doi: 10.3389/fbioe.2015.00168.
Pröschel, M., Detsch, R., Boccaccini, A. R., & Sonnewald, U. (2015). Engineering of Metabolic Pathways by Artificial Enzyme Channels. Frontiers in bioengineering and biotechnology, 3168. https://doi.org/10.3389/fbioe.2015.00168
Pröschel, Marlene, et al. "Engineering of Metabolic Pathways by Artificial Enzyme Channels." Frontiers in bioengineering and biotechnology vol. 3 (2015): 168. doi: https://doi.org/10.3389/fbioe.2015.00168
Pröschel M, Detsch R, Boccaccini AR, Sonnewald U. Engineering of Metabolic Pathways by Artificial Enzyme Channels. Front Bioeng Biotechnol. 2015 Oct 21;3:168. doi: 10.3389/fbioe.2015.00168. eCollection 2015. PMID: 26557643; PMCID: PMC4617052.
Copy Download .nbib Format: NLM
Highly Porous Materials with Unique Mechanical Properties from Smart Capillary Suspensions.

Advanced materials (Deerfield Beach, Fla.)

Dittmann J, Maurath J, Bitsch B, Willenbacher N.
PMID: 26677099
Adv Mater. 2016 Feb 24;28(8):1689-96. doi: 10.1002/adma.201504910. Epub 2015 Dec 16.

Smart capillary suspensions are used to fabricate macroporous solids with unique features regarding porosity and mechanical strength from a wide range of materials, including carbon layers and polyethylene membranes, even if sintering or high-temperature treatment is not feasible. High-strength...

Cite
Dittmann J, Maurath J, Bitsch B, et al. Highly Porous Materials with Unique Mechanical Properties from Smart Capillary Suspensions. Adv Mater. 2015;28(8):1689-96doi: 10.1002/adma.201504910.
Dittmann, J., Maurath, J., Bitsch, B., & Willenbacher, N. (2016). Highly Porous Materials with Unique Mechanical Properties from Smart Capillary Suspensions. Advanced materials (Deerfield Beach, Fla.), 28(8), 1689-96. https://doi.org/10.1002/adma.201504910
Dittmann, Jens, et al. "Highly Porous Materials with Unique Mechanical Properties from Smart Capillary Suspensions." Advanced materials (Deerfield Beach, Fla.) vol. 28,8 (2016): 1689-96. doi: https://doi.org/10.1002/adma.201504910
Dittmann J, Maurath J, Bitsch B, Willenbacher N. Highly Porous Materials with Unique Mechanical Properties from Smart Capillary Suspensions. Adv Mater. 2016 Feb 24;28(8):1689-96. doi: 10.1002/adma.201504910. Epub 2015 Dec 16. PMID: 26677099.
Copy Download .nbib Format: NLM
[Differential diagnosis of joint pain].

Schmerz (Berlin, Germany)

Bitsch T.
PMID: 12799976
Schmerz. 1998 Jul 10;12(3):223-37. doi: 10.1007/s004829800024.

No abstract available.

Cite
Bitsch T. Differentialdiagnose des Gelenkschmerzes. [Differential diagnosis of joint pain]. Schmerz. 1998;12(3):223-37doi: 10.1007/s004829800024.
Bitsch, T. (1998). Differentialdiagnose des Gelenkschmerzes. [Differential diagnosis of joint pain]. Schmerz (Berlin, Germany), 12(3), 223-37. https://doi.org/10.1007/s004829800024
Bitsch, T. "Differentialdiagnose des Gelenkschmerzes." [Differential diagnosis of joint pain]. Schmerz (Berlin, Germany) vol. 12,3 (1998): 223-37. doi: https://doi.org/10.1007/s004829800024
Bitsch T. Differentialdiagnose des Gelenkschmerzes. [Differential diagnosis of joint pain]. Schmerz. 1998 Jul 10;12(3):223-37. doi: 10.1007/s004829800024. German. PMID: 12799976.
Copy Download .nbib Format: NLM
Lysophosphatidylcholine and Cellular Potassium Loss in Isolated Rabbit Ventricle.

Journal of cardiovascular pharmacology and therapeutics

Goldhaber JI, Deutsch N, Alexander LD, Weiss JN.
PMID: 10684479
J Cardiovasc Pharmacol Ther. 1998 Jan;3(1):37-42. doi: 10.1177/107424849800300105.

BACKGROUND: Lysophospholipids such as lysophosphatidylcholine (LPC) have many direct electrophysiological effects on cardiac muscle and have been implicated as a cause of lethal ventricular arrhythmias during acute myocardial ischemia. Because extracellular K(+) accumulation is also a key arrhythmogenic factor...

Cite
Goldhaber JI, Deutsch N, Alexander LD, et al. Lysophosphatidylcholine and Cellular Potassium Loss in Isolated Rabbit Ventricle. J Cardiovasc Pharmacol Ther. 1998;3(1):37-42doi: 10.1177/107424849800300105.
Goldhaber, J. I., Deutsch, N., Alexander, L. D., & Weiss, J. N. (1998). Lysophosphatidylcholine and Cellular Potassium Loss in Isolated Rabbit Ventricle. Journal of cardiovascular pharmacology and therapeutics, 3(1), 37-42. https://doi.org/10.1177/107424849800300105
Goldhaber, et al. "Lysophosphatidylcholine and Cellular Potassium Loss in Isolated Rabbit Ventricle." Journal of cardiovascular pharmacology and therapeutics vol. 3,1 (1998): 37-42. doi: https://doi.org/10.1177/107424849800300105
Goldhaber JI, Deutsch N, Alexander LD, Weiss JN. Lysophosphatidylcholine and Cellular Potassium Loss in Isolated Rabbit Ventricle. J Cardiovasc Pharmacol Ther. 1998 Jan;3(1):37-42. doi: 10.1177/107424849800300105. PMID: 10684479.
Copy Download .nbib Format: NLM
Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.

Journal of carcinogenesis

Wahnschaffe U, Bitsch A, Kielhorn J, Mangelsdorf I.
PMID: 15655069
J Carcinog. 2005 Jan 17;4(1):3. doi: 10.1186/1477-3163-4-3.

As part of a larger literature study on transgenic animals in mutagenicity testing, test results from the transgenic mutagenicity assays (lacI model; commercially available as the Big Blue(R) mouse, and the lacZ model; commercially available as the Mutatrade markMouse),...

Cite
Wahnschaffe U, Bitsch A, Kielhorn J, et al. Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test. J Carcinog. 2005;4(1):3doi: 10.1186/1477-3163-4-3.
Wahnschaffe, U., Bitsch, A., Kielhorn, J., & Mangelsdorf, I. (2005). Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test. Journal of carcinogenesis, 4(1), 3. https://doi.org/10.1186/1477-3163-4-3
Wahnschaffe, U, et al. "Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test." Journal of carcinogenesis vol. 4,1 (2005): 3. doi: https://doi.org/10.1186/1477-3163-4-3
Wahnschaffe U, Bitsch A, Kielhorn J, Mangelsdorf I. Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test. J Carcinog. 2005 Jan 17;4(1):3. doi: 10.1186/1477-3163-4-3. PMID: 15655069; PMCID: PMC548135.
Copy Download .nbib Format: NLM
Symposium-"What Every Health Officer Should Know": Public Health Nursing.

American journal of public health and the nation's health

Deutsch N.
PMID: 18014912
Am J Public Health Nations Health. 1938 Sep;28(9):1087-90. doi: 10.2105/ajph.28.9.1087.

No abstract available.

Cite
Deutsch N. Symposium-"What Every Health Officer Should Know": Public Health Nursing. Am J Public Health Nations Health. 1938;28(9):1087-90doi: 10.2105/ajph.28.9.1087.
Deutsch, N. (1938). Symposium-"What Every Health Officer Should Know": Public Health Nursing. American journal of public health and the nation's health, 28(9), 1087-90. https://doi.org/10.2105/ajph.28.9.1087
Deutsch, N. "Symposium-"What Every Health Officer Should Know": Public Health Nursing." American journal of public health and the nation's health vol. 28,9 (1938): 1087-90. doi: https://doi.org/10.2105/ajph.28.9.1087
Deutsch N. Symposium-"What Every Health Officer Should Know": Public Health Nursing. Am J Public Health Nations Health. 1938 Sep;28(9):1087-90. doi: 10.2105/ajph.28.9.1087. PMID: 18014912; PMCID: PMC1527978.
Copy Download .nbib Format: NLM
The endoskeletal structures in arthropods: cytology, morphology and evolution.

Arthropod structure & development

Bitsch C, Bitsch J.
PMID: 18088953
Arthropod Struct Dev. 2002 Feb;30(3):159-77. doi: 10.1016/s1467-8039(01)00032-9.

The paper proposes an overview of the endoskeletal structures of the head and trunk in the different arthropod groups: Chelicerata, Crustacea, Myriapoda and Hexapoda (=Insecta s.l.). Two major endoskeletal systems are reported with their cytological characteristics: those made up...

Cite
Bitsch C, Bitsch J. The endoskeletal structures in arthropods: cytology, morphology and evolution. Arthropod Struct Dev. 2002;30(3):159-77doi: 10.1016/s1467-8039(01)00032-9.
Bitsch, C., & Bitsch, J. (2002). The endoskeletal structures in arthropods: cytology, morphology and evolution. Arthropod structure & development, 30(3), 159-77. https://doi.org/10.1016/s1467-8039(01)00032-9
Bitsch, Colette, and Bitsch, Jacques. "The endoskeletal structures in arthropods: cytology, morphology and evolution." Arthropod structure & development vol. 30,3 (2002): 159-77. doi: https://doi.org/10.1016/s1467-8039(01)00032-9
Bitsch C, Bitsch J. The endoskeletal structures in arthropods: cytology, morphology and evolution. Arthropod Struct Dev. 2002 Feb;30(3):159-77. doi: 10.1016/s1467-8039(01)00032-9. PMID: 18088953.
Copy Download .nbib Format: NLM
Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?.

World journal of hepatology

Ghanem LY, Dahmen U, Dirsch O, Nosseir MM, Mahmoud SS, Mansour WA.
PMID: 21191519
World J Hepatol. 2010 Dec 27;2(12):434-41. doi: 10.4254/wjh.v2.i12.434.

AIM: To introduce Granulocyte-colony stimulating factor (G-CSF) as a new therapeutic modality for schistosomiasis through stem cell mobilization, immunomodulation or fibrosis remodeling.METHODS: In this study, a 5 d course of human recombinant G-CSF (100 μg/kg sc) was applied to...

Cite
Ghanem LY, Dahmen U, Dirsch O, et al. Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?. World J Hepatol. 2010;2(12):434-41doi: 10.4254/wjh.v2.i12.434.
Ghanem, L. Y., Dahmen, U., Dirsch, O., Nosseir, M. M., Mahmoud, S. S., & Mansour, W. A. (2010). Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?. World journal of hepatology, 2(12), 434-41. https://doi.org/10.4254/wjh.v2.i12.434
Ghanem, Lobna Y, et al. "Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?." World journal of hepatology vol. 2,12 (2010): 434-41. doi: https://doi.org/10.4254/wjh.v2.i12.434
Ghanem LY, Dahmen U, Dirsch O, Nosseir MM, Mahmoud SS, Mansour WA. Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?. World J Hepatol. 2010 Dec 27;2(12):434-41. doi: 10.4254/wjh.v2.i12.434. PMID: 21191519; PMCID: PMC3010513.
Copy Download .nbib Format: NLM
Strain-induced macroscopic magnetic anisotropy from smectic liquid-crystalline elastomer-maghemite nanoparticle hybrid nanocomposites.

Nanoscale

Haberl JM, Sánchez-Ferrer A, Mihut AM, Dietsch H, Hirt AM, Mezzenga R.
PMID: 23677459
Nanoscale. 2013 Jun 21;5(12):5539-48. doi: 10.1039/c3nr01016c.

We combine tensile strength analysis and X-ray scattering experiments to establish a detailed understanding of the microstructural coupling between liquid-crystalline elastomer (LCE) networks and embedded magnetic core-shell ellipsoidal nanoparticles (NPs). We study the structural and magnetic re-organization at different...

Cite
Haberl JM, Sánchez-Ferrer A, Mihut AM, et al. Strain-induced macroscopic magnetic anisotropy from smectic liquid-crystalline elastomer-maghemite nanoparticle hybrid nanocomposites. Nanoscale. 2013;5(12):5539-48doi: 10.1039/c3nr01016c.
Haberl, J. M., Sánchez-Ferrer, A., Mihut, A. M., Dietsch, H., Hirt, A. M., & Mezzenga, R. (2013). Strain-induced macroscopic magnetic anisotropy from smectic liquid-crystalline elastomer-maghemite nanoparticle hybrid nanocomposites. Nanoscale, 5(12), 5539-48. https://doi.org/10.1039/c3nr01016c
Haberl, Johannes M, et al. "Strain-induced macroscopic magnetic anisotropy from smectic liquid-crystalline elastomer-maghemite nanoparticle hybrid nanocomposites." Nanoscale vol. 5,12 (2013): 5539-48. doi: https://doi.org/10.1039/c3nr01016c
Haberl JM, Sánchez-Ferrer A, Mihut AM, Dietsch H, Hirt AM, Mezzenga R. Strain-induced macroscopic magnetic anisotropy from smectic liquid-crystalline elastomer-maghemite nanoparticle hybrid nanocomposites. Nanoscale. 2013 Jun 21;5(12):5539-48. doi: 10.1039/c3nr01016c. PMID: 23677459.
Copy Download .nbib Format: NLM
Vascular complications following therapeutic and diagnostic cardiac catheterisation by the femoral artery.

The International journal of risk & safety in medicine

Bitsch M, Liisberg-Larsen O, Schroeder TV.
PMID: 23511256
Int J Risk Saf Med. 1994;4(3):191-5. doi: 10.3233/JRS-1994-4302.

Twenty-one of 6327 (0.33%) patients undergoing cardiac catheterisation via the femoral artery had an acute vascular complication requiring surgical intervention. The complication rate was 0.1% after coronary angiography, 2% after PTCA and 6% after aortic ballon dilatation. The size...

Cite
Bitsch M, Liisberg-Larsen O, Schroeder TV. Vascular complications following therapeutic and diagnostic cardiac catheterisation by the femoral artery. Int J Risk Saf Med. 1994;4(3):191-5doi: 10.3233/JRS-1994-4302.
Bitsch, M., Liisberg-Larsen, O., & Schroeder, T. V. (1994). Vascular complications following therapeutic and diagnostic cardiac catheterisation by the femoral artery. The International journal of risk & safety in medicine, 4(3), 191-5. https://doi.org/10.3233/JRS-1994-4302
Bitsch, M, et al. "Vascular complications following therapeutic and diagnostic cardiac catheterisation by the femoral artery." The International journal of risk & safety in medicine vol. 4,3 (1994): 191-5. doi: https://doi.org/10.3233/JRS-1994-4302
Bitsch M, Liisberg-Larsen O, Schroeder TV. Vascular complications following therapeutic and diagnostic cardiac catheterisation by the femoral artery. Int J Risk Saf Med. 1994;4(3):191-5. doi: 10.3233/JRS-1994-4302. PMID: 23511256.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 191 entries